• ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) Given Average Recommendation of "Buy" by Analysts

    Source: Buzz FX / 11 Feb 2025 01:51:10   America/Chicago


    ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) Given Average Recommendation of "Buy" by Analysts Written by MarketBeat February 11, 2025 Share Link copied to clipboard. Shares of ARS Pharmaceuticals, Inc. ( NASDAQ:SPRY - Get Free Report ) have bee
    Read more...
Share on,